Floatz logo

VONOPRAZAN

Helicobacter Pylori Infection

Nanjing First Hospital, Nanjing Medical UniversitySmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
89/ 100

Competitive context

5 Active assets in the Helicobacter Pylori Infection cohort.

Asset / SponsorPhaseRating
Amoxicillin
Nanjing First Hospital, Nanjing Medical University
Phase 4BBB
Clarithromycin
Sohag University
Phase 4BB
BISMUTH SALICYLATE
Fatih Sultan Mehmet Training and Research Hospital
Phase 4BB
Omeprazole
Fatih Sultan Mehmet Training and Research Hospital
Phase 4BB
Esomeprazole
Sohag University
Phase 2/3B
Orelabrutinib
Fudan University
Phase 2CCC
Huazhi Rougan Granule
Nanjing First Hospital, Nanjing Medical University
N/AD

Same molecule, other indications

VONOPRAZAN is also rated in:

HELICOBACTER PYLORI INFECTIONSDormant
BB
Indicative ·
65 / 100
View asset →
esophageal varicesDormant
B
Indicative ·
60 / 100
View asset →
Metabolic SyndromeDormant
B
Indicative ·
59 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →